Organon & Co. (OGN): Dividends Paid
$88.00M
Year ended 2025-12-31
$18.00M
Trailing 12 months to 2026-06-30
-32.8%
3-year compound annual growth
| Period ended | Dividends Paid | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $88.00M | -70.4% | 2026-02-24, From 2025-01-01 |
| 2024-12-31 | $297.00M | +1.0% | 2026-02-24, From 2024-01-01 |
| 2023-12-31 | $294.00M | +1.4% | 2026-02-24, From 2023-01-01 |
| 2022-12-31 | $290.00M | +100.0% | 2025-11-10, From 2022-01-01 |
| 2021-12-31 | $145.00M | n/a | 2024-02-26, From 2021-01-01 |
| 2020-12-31 | $0 | n/a | 2023-02-27, From 2020-01-01 |
| 2019-12-31 | $0 | n/a | 2022-03-21, From 2019-01-01 |
Dividends Paid at similar companies
| Company | Year ended | Dividends Paid | Change YoY |
|---|---|---|---|
| Organon & Co. (OGN) | 2025-12-31 | $88.00M | -70.4% |
| Perrigo Co PLC (PRGO) | 2025-12-31 | $159.30M | +4.5% |
| Regeneron Pharmaceuticals, Inc. (REGN) | 2025-12-31 | $370.30M | n/a |
| Phibro Animal Health Corp (PAHC) | 2026-06-30 | $19.46M | +0.1% |
| ANI Pharmaceuticals Inc (ANIP) | 2025-12-31 | $1.16M | -28.8% |
| Abbott Laboratories (ABT) | 2025-12-31 | $4.12B | +7.3% |
| Bristol Myers Squibb Co (BMY) | 2025-12-31 | $5.04B | +3.7% |
| AbbVie Inc. (ABBV) | 2025-12-31 | $11.66B | +5.7% |
| Merck & Co., Inc. (MRK) | 2025-12-31 | $8.18B | +4.3% |
Compare OGN, PRGO, REGN, PAHC side by side · Screen every company in Pharmaceutical Preparations ↗